Literature DB >> 20861221

Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.

Nathalie di Clemente1, Soazik P Jamin, Alexey Lugovskoy, Paul Carmillo, Christian Ehrenfels, Jean-Yves Picard, Adrian Whitty, Nathalie Josso, R Blake Pepinsky, Richard L Cate.   

Abstract

TGF-β family ligands are translated as prepropeptide precursors and are processed into mature C-terminal dimers that signal by assembling a serine/threonine kinase receptor complex containing type I and II components. Many TGF-β ligands are secreted in a latent form that cannot bind their receptor, due to the pro-region remaining associated with the mature ligand in a noncovalent complex after proteolytic cleavage. Here we show that anti-Müllerian hormone (AMH), a TGF-β family ligand involved in reproductive development, must be cleaved to bind its type II receptor (AMHRII), but dissociation of the pro-region from the mature C-terminal dimer is not required for this initial interaction. We provide direct evidence for this interaction by showing that the noncovalent complex binds to a soluble form of AMHRII in an ELISA format and to AMHRII immobilized on Sepharose. Binding of the noncovalent complex to Sepharose-coupled AMHRII induces dissociation of the pro-region from the mature C-terminal dimer, whereas no dissociation occurs after binding to immobilized AMH antibodies. The pro-region cannot be detected after binding of the AMH noncovalent complex to AMHRII expressed on COS cells, indicating that pro-region dissociation may occur as a natural consequence of receptor engagement on cells. Moreover, the mature C-terminal dimer is more active than the noncovalent complex in stimulating Sma- and Mad-related protein activation, suggesting that pro-region dissociation contributes to the assembly of the active receptor complex. AMH thus exemplifies a new mechanism for receptor engagement in which interaction with the type II receptor promotes pro-region dissociation to generate mature ligand.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861221      PMCID: PMC5417381          DOI: 10.1210/me.2010-0273

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  51 in total

Review 1.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

2.  Biochemical and biophysical characterization of refolded Drosophila DPP, a homolog of bone morphogenetic proteins 2 and 4.

Authors:  J Groppe; K Rumpel; A N Economides; N Stahl; W Sebald; M Affolter
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

Review 3.  TGF-beta latency: biological significance and mechanisms of activation.

Authors:  P E Gleizes; J S Munger; I Nunes; J G Harpel; R Mazzieri; I Noguera; D B Rifkin
Journal:  Stem Cells       Date:  1997       Impact factor: 6.277

4.  GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding.

Authors:  R S Thies; T Chen; M V Davies; K N Tomkinson; A A Pearson; Q A Shakey; N M Wolfman
Journal:  Growth Factors       Date:  2001       Impact factor: 2.511

5.  Crystal structure of BMP-9 and functional interactions with pro-region and receptors.

Authors:  Monica A Brown; Qinghai Zhao; Kent A Baker; Chethana Naik; Cecil Chen; Laurie Pukac; Mallika Singh; Tatiana Tsareva; Yanick Parice; Angela Mahoney; Viktor Roschke; Indra Sanyal; Senyon Choe
Journal:  J Biol Chem       Date:  2005-04-25       Impact factor: 5.157

6.  Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.

Authors:  C A Wilson; N di Clemente; C Ehrenfels; R B Pepinsky; N Josso; B Vigier; R L Cate
Journal:  Mol Endocrinol       Date:  1993-02

7.  Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases.

Authors:  Neil M Wolfman; Alexandra C McPherron; William N Pappano; Monique V Davies; Kening Song; Kathleen N Tomkinson; Jill F Wright; Liz Zhao; Suzanne M Sebald; Daniel S Greenspan; Se-Jin Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

8.  Müllerian-inhibiting substance function during mammalian sexual development.

Authors:  R R Behringer; M J Finegold; R L Cate
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

9.  Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.

Authors:  G D Orvis; S P Jamin; K M Kwan; Y Mishina; V M Kaartinen; S Huang; A B Roberts; L Umans; D Huylebroeck; A Zwijsen; D Wang; J F Martin; R R Behringer
Journal:  Biol Reprod       Date:  2008-03-05       Impact factor: 4.285

10.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.

Authors:  P ten Dijke; H Yamashita; T K Sampath; A H Reddi; M Estevez; D L Riddle; H Ichijo; C H Heldin; K Miyazono
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

View more
  39 in total

1.  Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer.

Authors:  Tim N Beck; Vladislav A Korobeynikov; Alexander E Kudinov; Rachel Georgopoulos; Nehal R Solanki; Magda Andrews-Hoke; Timothy M Kistner; David Pépin; Patricia K Donahoe; Emmanuelle Nicolas; Margret B Einarson; Yan Zhou; Yanis Boumber; David A Proia; Ilya G Serebriiskii; Erica A Golemis
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

2.  Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome.

Authors:  Lidija K Gorsic; Gulum Kosova; Brian Werstein; Ryan Sisk; Richard S Legro; M Geoffrey Hayes; Jose M Teixeira; Andrea Dunaif; Margrit Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

3.  A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing.

Authors:  Takuya Akiyama; Guillermo Marqués; Kristi A Wharton
Journal:  Sci Signal       Date:  2012-04-03       Impact factor: 8.192

4.  Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer.

Authors:  Jae Yen Song; Hyun Hee Jo; Mee Ran Kim; Young Oak Lew; Ki Sung Ryu; Jung Ho Cha; Chang Suk Kang; Patricia K Donahoe; David T MacLaughlin; Jang Heub Kim
Journal:  Int J Oncol       Date:  2012-02-14       Impact factor: 5.650

5.  Anti-Müllerian hormone is a survival factor and promotes the growth of rhesus macaque preantral follicles during matrix-free culture.

Authors:  Jing Xu; Fuhua Xu; Maralee S Lawson; Olena Y Tkachenko; Alison Y Ting; Christoph A Kahl; Byung S Park; Richard R Stouffer; Cecily V Bishop
Journal:  Biol Reprod       Date:  2018-02-01       Impact factor: 4.285

Review 6.  Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function.

Authors:  Anne-Laure Barbotin; Maëliss Peigné; Samuel Andrew Malone; Paolo Giacobini
Journal:  Neuroendocrinology       Date:  2019-07-05       Impact factor: 4.914

7.  Alternative cleavage of the bone morphogenetic protein (BMP), Gbb, produces ligands with distinct developmental functions and receptor preferences.

Authors:  Edward N Anderson; Kristi A Wharton
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

8.  Primary Sertoli Cell Cultures From Adult Mice Have Different Properties Compared With Those Derived From 20-Day-Old Animals.

Authors:  Arpornrad Saewu; Kessiri Kongmanas; Riya Raghupathy; Jacob Netherton; Suraj Kadunganattil; James-Jules Linton; Watchadaporn Chaisuriyong; Kym F Faull; Mark A Baker; Nongnuj Tanphaichitr
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

9.  An albumin leader sequence coupled with a cleavage site modification enhances the yield of recombinant C-terminal Mullerian Inhibiting Substance.

Authors:  D Pépin; M Hoang; F Nicolaou; K Hendren; L A Benedict; A Al-Moujahed; A Sosulski; A Marmalidou; D Vavvas; P K Donahoe
Journal:  Technology       Date:  2013-09

10.  Adjusting antimüllerian hormone levels for age and body mass index improves detection of polycystic ovary syndrome.

Authors:  Glenn E Palomaki; Bhanu Kalra; Tanya Kumar; Amita S Patel; Gopal Savjani; Laura C Torchen; Andrea Dunaif; Anthony Morrison; Geralyn M Lambert-Messerlian; Ajay Kumar
Journal:  Fertil Steril       Date:  2020-03-05       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.